GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC
Conditions
Hepatocellular Carcinoma · Liver Cancer, Adult · Liver Neoplasm · Metastatic Liver Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
City of Hope, Duarte, California, United States
Contact: Principal Investigator (Daneng Li, MD)Kansas University Medical Center, Principal Investigator:, Westwood, Kansas, United States
Roswell Park Comprehensive Cancer Center, Buffalo, New York, United States
Montefiore Einstein Comprehensive Cancer Center, The Bronx, New York, United States
Contact: Principal Investigator (R. Alejandro Sica, MD)Oregon Health and Sciences University, Portland, Oregon, United States
Contact: Principal Investigator (Richard Maziarz, MD)Adel Kardosh, MD (Sub-investigator)University of Texas Southwestern, Harold C. Simmons Comprehensive Cancer Center, Dallas, Texas, United States
Contact: Principal Investigator (David Hsieh, MD)Farrukh Awan, MD (Sub-investigator)Fred Hutchinson Cancer Center, University of Washington, Seattle, Washington, United States
Contact: Principal Investigator (William Harris, MD)National Taiwan University Cancer Center, Taipei, Taiwan
Contact: Principal Investigator (Chiun Hsu, MD, PhD)
Study leads
Pei Wang, PhD
Study Director
Eureka Therapeutics Inc.